Drug: REBIF Injury: Multiple sclerosis relapse Quarter: 2016Q3
Total Records: 17 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125208681 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 43.33 YR | F | 0 | 20160701 | US |
| 126342273 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 68.02 YR | F | 0 | 20160908 | US |
| 126513841 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 61.00 YR | M | 0 | 20160815 | DE |
| 126564581 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 56.00 YR | F | 0 | 20160816 | US |
| 126593001 | REBIF | Multiple sclerosis relapse | TEVA | 0.00 | F | 0 | 20160817 | US |
| 126866821 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 56.00 YR | F | 0 | 20160825 | US |
| 126960511 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 30.88 YR | F | 0 | 20160829 | US |
| 127016281 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 0.00 | F | 0 | 20160831 | US |
| 127019041 | REBIF | Multiple sclerosis relapse | 62.00 YR | F | 0 | 20160830 | US | |
| 127252521 | REBIF | Multiple sclerosis relapse | FDA-CTU | 61.00 YR | F | 0 | 20160906 | US |
| 127301971 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 28.00 YR | M | 0 | 20160909 | US |
| 127354361 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 27.00 YR | F | 0 | 20160912 | US |
| 127464521 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 56.29 YR | M | 55 KG | 20160915 | BR |
| 127582481 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 0.00 | F | 0 | 20160919 | DE |
| 127621441 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 45.00 YR | F | 0 | 20160920 | US |
| 127636171 | REBIF | Multiple sclerosis relapse | TEVA | 45.00 YR | F | 0 | 20160920 | US |
| 127793831 | REBIF | Multiple sclerosis relapse | EMD SERONO INC | 64.11 YR | F | 0 | 20160926 | US |
Total Records: 17 Number of Pages: 1